← Back to all trials
Recruiting
NCT07867431
Effects of Incentive Spirometry Versus Diaphragmatic Breathing on Oxygen Saturation and Heart-rate Variability in Post Percutaneous Coronary Intervention Patients
Conditions: Percutaneous Coronary Intervention Patients
Sex: All
Ages: 44 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 36
Sponsor: Foundation University Islamabad
Location: Foundation University Islamabad Rawalpindi
Summary
This study is a two-arm randomized parallel group trial designed to compare the effects of Incentive spirometry vs diaphragmatic breathing on oxygen saturation and Heart-rate variability in hemodynamically stable post-PCI patients. Participants will be randomly allocated to either the incentive spirometry group or the diaphragmatic breathing group and will receive the allocated intervention for 2 consecutive days with three supervised sessions per day in addition to routine post-PCI care. Oxygen saturation will be assessed using a pulse oximeter and heart-rate variability will be assessed using a Polar H10 sensor at baseline and after the intervention. The study will determine whether there is a difference between two interventions in the prescribed outcome measures.
Eligibility Criteria
Inclusion Criteria:
* Adults aged 44-75 years
* Hemodynamically stable post-PCI patients with systolic blood pressure\>90 mmHg, diastolic BP 50-100mmHg Heart-rate 60-100 beats/min and no ongoing chest pain or signs of acute clinical instability.
* Oxygen saturation \>92% on room air
* Able to follow simple verbal instructions and perform the breathing exercises.
* Ejection Fraction \>35%
Exclusion Criteria:
* Ongoing myocardial ischemia, unstable angina, significant arrythmia or requirement for inotropic/vasopressor support.
* Cardiogenic shock or severe heart failure (NYHA class IV)
* Recent thoracic surgery or chest wall injury limiting rib expansion or deep breathing.
* Cardiac implantable electronic device (pacemaker/ICD) with pacing dependency or an implanted ventricular assist device.
* Severe cognitive impairment
* Uncontrolled hypertension(SBP\>180 mmHg or DBP\>110 mmHg) or bradycardia\
Source: ClinicalTrials.gov (NCT07867431). StuddyBuddy aggregates publicly available trial information.